Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hanjia Design Group
300746
5
Harbin Jiuzhou Group
300040
US OptionsDetailed Quotes
MRVI250516C2000
- 0.15
- 0.000.00%
15min DelayTrading Apr 22 09:39 ET
0.00High0.00Low
0.00Open0.15Pre Close0 Volume217 Open Interest2.00Strike Price0.00Turnover75.43%IV6.44%PremiumMay 16, 2025Expiry Date0.02Intrinsic Value100Multiplier21DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type0.5469Delta1.0854Gamma13.47Leverage Ratio-0.0035Theta0.0006Rho7.36Eff Leverage0.0019Vega
Maravai LifeSciences Newsroom
RBC Capital Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $7
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Maintains Target Price $5
Analysts Offer Insights on Healthcare Companies: Opthea Limited (OtherCKDXF), Outset Medical (OM) and Maravai Lifesciences Holdings (MRVI)
Maravai LifeSciences Is Maintained at Equal-Weight by Morgan Stanley
RBC Capital Reaffirms Their Buy Rating on Maravai Lifesciences Holdings (MRVI)
Morgan Stanley Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $5
William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
Stifel Maintains Maravai LifeSciences(MRVI.US) With Buy Rating, Cuts Target Price to $5
UBS Maintains Maravai LifeSciences(MRVI.US) With Hold Rating, Cuts Target Price to $2.5
Maravai LifeSciences Analyst Ratings
UBS Maintains Neutral on Maravai LifeSciences, Lowers Price Target to $2.5
Strategic Acquisitions and Market Expansion Drive Buy Rating for Maravai Lifesciences Holdings
UBS Cuts Price Target on Maravai Lifesciences to $2.50 From $8, Keeps Neutral Rating
Deutsche Bank Adjusts Price Target on Maravai Lifesciences to $5 From $10, Keeps Buy Rating
Jefferies Initiates Maravai LifeSciences(MRVI.US) With Buy Rating, Announces Target Price $10
Craig-Hallum Maintains Maravai LifeSciences(MRVI.US) With Buy Rating
William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
Buy Rating for Maravai Lifesciences Holdings: Strategic Financial Decisions and Growth Potential Amidst Challenges
William Blair Reaffirms Their Hold Rating on Maravai Lifesciences Holdings (MRVI)
William Blair Maintains Maravai LifeSciences(MRVI.US) With Hold Rating
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call